Fri, Mar 24, 2023
Volume 1, Issue 3 (JULY 2002)                   Payesh 2002, 1(3): 11-15 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Farrokh Slamloo H.R, Eftekhar H, Holakouei Naeini K, Rahimi Foroushani. Rubella seroepidemiology in 0-45 years old no vaccinated population and determining the best national immunization strategy: a community survey, Uremia, Iran . Payesh 2002; 1 (3) :11-15
Abstract:   (5384 Views)
Objcctive(s): To determine age-specific rubella seroprevalence in the O to 45 years-old unvaccinated population in Uremia, Iran and also to propose a vaccination strategy against rubella this study designed. Material & Methods: A total of 770 unvaccinated persons O to 45 years old were selected for the study with cluster sampling. Sera from 392 females and 378 males were tested for rubella IgG antibody using enzyme linked immonosurbent assay (ELIZA) technique. Rubella seropositivity was defined as serum rubella IgG antibody level> or= I 3IU/ml.
Results: Of the 770 cases, 58.1 % were seropositive. Due to maternal derived antibodies, 100% of the newborns was seropositive. This figure decreased with time until it became zero in children aged 9 months.  Then from years 4 increased with age gradually until it peaked at 93.4% in the age group of 15-
19 years. The seropositivity decreased to 85.7%   in   the age group   of >35 years.  Of women in the reproductive age groups (15-45years old), 89.6% were seropositive.
Conclusion:-. Because a substantial proportion of women in their childbearing years are susceptible to rubella, immunization efforts should be directed at infants and/or prepubertal children.
Full-Text [PDF 206 kb]   (1699 Downloads)    
type of study: Descriptive |
Accepted: 2018/11/28 | Published: 2002/07/15

Add your comments about this article : Your username or Email:

Rights and Permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 All Rights Reserved | Payesh (Health Monitor)

Designed & Developed by : Yektaweb